• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION; SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION; SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE Back to Search Results
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problems Abdominal Pain (1685); Peritonitis (2252)
Event Date 12/18/2023
Event Type  Injury  
Event Description
A peritoneal dialysis (pd) patient experienced a breach in aseptic technique which resulted in peritonitis.The breach in aseptic technique was further described as due to a hygiene issue.The peritonitis was manifested stomach pain and dark effluent.The patient presented to the emergency department; however, the patient was not hospitalized for the event.On an unknown date, the patient was initially treated with ceftazidime (discontinued).On an unknown date, the month of the peritonitis onset, the patient was treated with vancomycin (intraperitoneal, 2 g every five days, ongoing).Approximately two months after event onset, the patient experienced dark effluent.No other symptoms were noted.It was reported that the "patient did not really recover from the first episode of peritonitis".The patient was treated with unspecified intraperitoneal antibiotics and heparin.At the time of the report, the patient was recovering from peritonitis.It was not reported if the patient was retrained on the proper aseptic technique.Pd therapy was ongoing.No additional information is available.
 
Manufacturer Narrative
B3: the events occurred on 18dec2023 and 20feb2024.This report is for a breach in aseptic technique which resulted in peritonitis.Per baxter labeling, users are instructed to use aseptic technique when performing peritoneal dialysis therapy.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NI
Type of Device
SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
Manufacturer (Section G)
BAXTER HEALTHCARE CORPORATION
ni
ni
ni
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 60073
2242702068
MDR Report Key18987604
MDR Text Key338723711
Report Number1416980-2024-01375
Device Sequence Number1
Product Code KDJ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
NI
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial
Report Date 03/27/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/06/2024
Initial Date FDA Received03/27/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CASSETTE; DIANEAL 1.5% PD4; DIANEAL 2.5% PD4 (AS NEEDED); DIANEAL 4.25% PD4 (AS NEEDED); EXTRANEAL 7.5%; MINI-CAP
Patient Outcome(s) Required Intervention;
Patient Age62 YR
Patient SexMale
-
-